Registration for Definitive LIVE! is now open. Definitive Healthcare’s second annual user conference takes place on May 17 from 12 - 3 p.m. ET.
Definitive Healthcare (Nasdaq: DH) launches Passport Analytics Suite, powered by Analytical Wizards, delivering data-agnostic analytics on-demand to…
Definitive Healthcare to present at the Raymond James 43rd Annual Institutional Investors Conference and the Deutsche Bank 30th Annual Media, Internet & Telecom Conference
Definitive Healthcare (Nasdaq: DH) will present at two conferences: Raymond James and Deutsche Bank.
Definitive Healthcare (Nasdaq: DH) announces financial results for the fourth quarter and full year ended December 31, 2021.
Definitive Healthcare has been named a 2022 Top Workplace USA by Energage in the category of companies with 500-999 employees.
Definitive Healthcare announces timing of its fourth quarter and full year 2021 financial results conference call and webcast
Definitive Healthcare announces its fourth quarter and full year financial results will be released on February 23, 2022 after market close.
Definitive Healthcare launches Latitude Discovery for pre-commercial biopharma and medical device companies
Definitive Healthcare announces the availability of Latitude Discovery, a new product aimed at pre-commercial biopharma & medical device companies.
Definitive Healthcare (Nasdaq: DH) is set to join the Russell 1000® Index effective after the U.S. stock market opens on December 20, 2021.
Chief Product Officer Kate Shamsuddin Jensen recognized by Boston Business Journal and 2021 Stevie Awards for Women in Business
Definitive Healthcare’s Chief Product Officer Kate Shamsuddin Jensen recognized by Boston Business Journal and Stevie Awards for Women in Business.